Mental Health and Physical Activity for Neuro Diverse Youth
Summary
Community-based physical activity programs for youth and young adults with neurodevelopmental disabilities provide not only an opportunity for exercise, but also for making friends. We know that exercise can help the health of our bodies and our minds. But we don't know specifically how it impacts quality of life, self-esteem, resilience, and internal perceptions for youth and young adults with a neurodevelopmental condition. We want to help learn about how much exercise might be optimal for youth and young adults with neurodevelopmental conditions to improve the health of their mind (mental health).
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 14 to 25
Inclusion criteria:
1a. I am 14 - 25 years of age.
2a. I have a neurodevelopmental disability (e.g., Autism, Down Syndrome, Cerebral Palsy, FASD, etc.).
3a. I communicate in English.
4a. I am taking part in a community-based physical activity program.
1b. My child is 14 - 25 years of age.
2b. My child has a neurodevelopmental disability (e.g., Autism, Down Syndrome, Cerebral Palsy, FASD, etc.) .
3b. I communicate in English.
4b. My child is taking part in a community-based physical activity program.
Exclusion criteria:
1. You are not eligible if you are older than 25 years or younger than 14 years of age.
2. You are not eligible if you do not have a medical condition.
3. You are not eligible if you are unable to communicate in English.
4. You are not eligible if you are not taking part in a community-based physical activity program(s).
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
cah.research@ucalgary.ca 403.955.5736
Principal investigator:
Carolyn Emery
Clinical trial:
No
REB-ID:
REB24-0245